insights_auto
Why is OCUL down 2.90%?
Dive Deeperchevron_right
OCUL:NASDAQ
Ocular Therapeutix Inc
$6.03
arrow_downward
-2.90%(-0.18) 1D
Nov 16, 2:13:03 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OCUL...
Open
$6.16
High
$6.25
Low
$5.94
Mkt. cap
1.33B
Avg. vol.
2.95M
Volume
1.73M
52-wk high
$16.44
52-wk low
$5.94
EPS
-$1.46
Beta
1.22
Shares outstanding
220.02M
No. of employees
325
Open
$6.16
High
$6.25
Low
$5.94
Mkt. cap
1.33B
Avg. vol.
2.95M
Volume
1.73M
52-wk high
$16.44
52-wk low
$5.94
EPS
-$1.46
Beta
1.22
Shares outstanding
220.02M
No. of employees
325
News stories
From web sources and news partners
The Korea Times
·
1 hour ago
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
ChartMill
·
1 hour ago
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
TradingView
·
2 hours ago
Forget Nvidia—Wall Street Sees S&P 500 at 8,900, Putting These ETFs in Play
The Motley Fool
·
44 minutes ago
McDonald's Is Underperforming the S&P 500 and Nasdaq-100. Could January Mark a Turning Point?
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees325
Founded2006
HeadquartersBedford, Massachusetts, United States
SectorHealth Care
IndustryPharmaceutical industry
Websiteocutx.com